- Clinical Outcome of Treatment with Infliximab in Crohn's Disease: A Single-Center Experience
-
Kim YJ, Kim JW, Lee CK, Park HJ, Shim JJ, Jang JY, Dong SH, Kim HJ, Kim BH, Chang YW
- KMID: 1501649
- Korean J Gastroenterol.
- 2013 May;61(5):270-278.
- doi: 10.4166/kjg.2013.61.5.270
BACKGROUND/AIMS: Our aim was to assess the long-term data regarding efficacy and safety of infliximab (IFX) treatment for refractory Crohn's disease (CD) patients in our tertiary teaching hospital. METHODS: We have... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Treatment with Infliximab in Crohn's Disease: the Experience of Single Center in Korea
-
Choi KD, Song HJ, Kim JS, Jung HC, Song IS
- KMID: 1767509
- Korean J Gastroenterol.
- 2005 Jul;46(1):48-55.
BACKGROUND/AIMS: Infliximab has been shown to be effective and safe for treating refractory luminal and fistulizing Crohn's disease (CD). The aim of this study was to report the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Occupational Rhinitis Caused by Porcine Pancreatic Extract Developing into Occupational Asthma
-
Shin SY, Hur GY, Ye YM, Park HS
- KMID: 1713474
- J Korean Med Sci.
- 2008 Apr;23(2):347-349.
- doi: 10.3346/jkms.2008.23.2.347
Porcine pancreatic extracts (PPE), which are widely used as a digestive drug in Korea, are composed of alpha-amylase and lipase. Such enzymes are commonly described as occupational allergens. This is... -
- CITED
-
- Close
- SHARE
-
- Close
